STAAR Surgical Company
STAANASDAQHealthcareMedical Instruments & Supplies
As of Oct 23, 2026 close
- Market cap
- $1.16B
- P/E (TTM)
- 7232.53
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $15.59$35.87
- Volume (live)
- -
- Avg. volume (3M)
- 879.71K
STAAR Surgical Company (STAA) Stock Price & Financial Analysis
STAAR Surgical Company Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $22.29 - $22.67 |
|---|---|
| 52-Week High | $35.87 |
| 52-Week Low | $15.59 |
| Open | $22.47 |
| Volume (last close) | 345.18K |
| Average Volume (3M) | 879.71K |
| Revenue (TTM) | 374.11M |
|---|---|
| Net Income (TTM) | 161.00K |
| Free Cash Flow (TTM) | -5.88M |
| EPS (TTM) | $0.00 |
| Profit Margin | 0.04% |
| Operating Margin | 3.38% |
| Return on Equity (ROE) | 0.04% |
| Debt to Equity | 0.10 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.16B |
|---|---|
| Shares Outstanding | 51.50M |
| P/E Ratio (TTM) | 7232.53 |
| Price to Sales (P/S) | 3.11 |
| Price to Book (P/B) | 3.19 |
| EV/EBITDA | 18.69 |
| 50-Day MA | $22.61 |
|---|---|
| 200-Day MA | $23.55 |
| 1-Year Change | −16.58% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
STAAR Surgical Company at a Glance
As of the Oct 23, 2026 close, STAAR Surgical Company (STAA) has a market capitalization of $1.16B. The stock trades at 7232.5× trailing earnings and 3.1× sales. Over the trailing twelve months it earned $161.00K on revenue of $374.11M (a 0.00% profit margin) and burned $5.88M of free cash flow. Revenue grew 46.9% year over year.
As of its latest reported balance sheet, it holds $148.58M in cash and securities against $37.29M of debt, a net cash position of $111.29M.
STAAR Surgical Company does not currently pay a dividend.
The share price is down 16.6% over the past year. At $22.61 (the Oct 23, 2026 close) it sits within its 52-week range of $15.59 to $35.87, below its 200-day moving average of $23.55.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $27.33, 20.9% above the Oct 23, 2026 close.
Frequently Asked Questions About STAAR Surgical Company
What is the current stock price for STAA?
As of the Oct 23, 2026 close, STAA stock trades at $22.61. The 52-week range is $15.59–$35.87, with a day range of $22.29–$22.67.
What is the P/E ratio for STAA?
As of the Oct 23, 2026 close, STAAR Surgical Company's trailing twelve-month (TTM) P/E ratio is 7232.5, meaning investors pay $7232.5 for every $1 of annual earnings. STAAR Surgical Company operates in the Healthcare sector.
Does STAA pay dividends?
STAAR Surgical Company does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for STAA?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for STAA is Hold. The average 12-month price target is $27.33, a 20.9% upside from the Oct 23, 2026 close of $22.61.
What is the market cap of STAA?
As of the Oct 23, 2026 close, STAAR Surgical Company's market capitalization is $1.16B, classifying it as a small-cap company. STAAR Surgical Company operates in the Healthcare sector within the Medical Instruments & Supplies industry.